Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 348

Posts Tagged ‘san francisco’

Global Industry Leaders to Showcase Real-World Digital Transformations at 2019 Alfresco Day San Francisco

Posted by fidest press agency su sabato, 12 gennaio 2019

Alfresco Software, a leading enterprise open source provider of process automation, content management and information governance software, will hold its annual Alfresco Day San Francisco from 8 a.m. to 5 p.m. on Tuesday, January 15, 2019, at the Bently Reserve.The one-day event brings together influential decision-makers and provides IT decision makers, Systems Architects and Developers with the opportunity to meet Alfresco ECM and process automation experts and industry peers.Bernadette Nixon, Chief Executive Officer, Alfresco, noted: “Today, it’s about putting content to work to drive competitive differentiation. The Alfresco Digital Business Platform offers process-led content management with information governance – all cloud native and built on open standards. This unique combination enables organizations to create new and enhanced user experiences at a speed and scale that were previously unattainable.” Attendees will learn what’s new and changing in the ECM industry, how they can leverage Amazon AWS services, how Blockchain can support record-keeping, how Machine Learning is impacting content management, and other topics exploring the future of content management and process automation.
Alfresco Software, Inc. (“Alfresco”) is an enterprise open source software company focused on advancing the flow of digital business. The company provides a better, more effortless way for people to work, making sure they have the information they need, exactly when they need it most. The Alfresco Digital Business Platform is used to digitize processes, manage content and securely govern information. Alfresco helps over 1,300 industry-leading organizations, including Cisco, Pitney Bowes, Capital One, US Department of Navy, the Joint Chiefs of Staff, and NASA, be more responsive and competitive. Founded in 2005, Alfresco has its U.S. headquarters in San Mateo, California, and European headquarters in Maidenhead, UK. For more information on Alfresco, please visit

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

BioSim Pharmaceuticals to Attend JP Morgan Healthcare Conference in San Francisco

Posted by fidest press agency su sabato, 15 dicembre 2018

Held annually alongside Biotech Showcase and OneMed Forum, the JP Morgan conference is one of the largest and most informative healthcare symposiums in the industry. BioSim will be meeting throughout the conference to update suppliers and interested parties on state of their research and development program.BioSim’s ACTH Gelatin Depot 80 IU/mL product is a copy of the branded drug H.P. ACTHAR®, manufactured by Mallinckrodt Plc (NYSE: MNK) which in 2014 purchased the previous owner, Questcor Pharmaceuticals (NASDAQ:QCOR) through a tax inversion valued at over $5 billion dollars. The injectable drug treats infantile spasms and rare autoimmune disorders like nephrotic syndrome and multiple sclerosis. BioSim has been advancing its ACTH (Corticotropin) Gel since 2012. With significant research and development, coupled with recent government guidance, its product has been demonstrated in-vitro and in-vivo to perform like ACTHAR. Over the past few decades, the market for specialty biopharmaceutical products for rare diseases has blossomed. For established companies like Teva (NYSE:Teva) and Cipla (NSE: CIPLA), as well as niche players like Depomed and Zydus Cadilla (NSE: CADILAHC), the US market continues to see rapid growth. BioSim has positioned itself to take advantage of that change, all with the goal of lowering the cost of medicine for America’s Healthcare System.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

NHI to Attend REITWorld 2018 in San Francisco

Posted by fidest press agency su domenica, 14 ottobre 2018

National Health Investors, Inc. (NYSE: NHI) announced that Eric Mendelsohn, President and CEO, along with other members of the senior management team, will be meeting with institutional investors at REITWorld 2018. The conference is to be held November 7 – 9, 2018, at the San Francisco Marriott Marquis in San Francisco, CA. Incorporated in 1991, National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Signature Bank Appoints Two Teams to Its New San Francisco Banking Office

Posted by fidest press agency su lunedì, 10 settembre 2018

Signature Bank (Nasdaq: SBNY), a New York-based full-service commercial bank, announced today the appointment of two private client banking teams, based at its San Francisco office on 201 Mission Street.Dale Zeigler and Sumiko Sheaffer were each named Group Director – Senior Vice President and will lead their own teams. These banking professionals previously worked with Joe Petitti, Signature Bank’s Head of West Coast Operations.Zeigler brings 33 years of commercial banking experience to his new role, with more than 20 years spent in the San Francisco market. Prior to joining Signature Bank, Zeigler was Vice President and Principal Business Relationship Manager with Wells Fargo Bank in San Francisco for 12 years, where he managed the financial needs of a large portfolio of middle market companies across various industries, including non-profit organizations. Earlier, Zeigler was Senior Vice President and Business Banking Manager at Business Bank of California (South San Francisco) and Assistant Vice President in Commercial Lending for The Pacific Bank in San Francisco.Sheaffer has 32 years of banking experience, 27 of which were spent at MUFG Union Bank, N.A. in San Francisco. Most recently, she served as Vice President and Relationship Manager in Asian Corporate Banking. In this role, Sheaffer managed U.S. subsidiaries of foreign corporations. Sheaffer was instrumental in acquiring large corporate accounts and building international banking relationships. She also held the previous role of Vice President and Relationship Manager for San Francisco Business Banking at MUFGJoining Zeigler’s team are Sergey Shikhvarg, named Associate Group Director and Charlotte Elopre, who was appointed to the post of Senior Client Associate-Officer.Most recently, Shikhvarg was a Vice President and Senior Commercial Relationship Manager at Bridge Bank, a division of Western Alliance Bank in San Francisco, where he managed commercial banking relationships. His banking career began at Wells Fargo as a Vice President and Principal Business Relationship Manager for San Francisco Business Banking.
Elopre, with 13 years of banking-related experience, worked with Zeigler at Wells Fargo in San Francisco as a Business Associate II, supporting business relationship managers. She also was a Personal Banker II for Wells Fargo’s Alameda, Calif. branch, and Assistant Branch Manager as well as Personal Banker for Wells Fargo’s San Leandro, Calif. branch.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

Ontology and Partners Participate in MainNet Pre-Launch Event in San Francisco

Posted by fidest press agency su lunedì, 2 luglio 2018

Ontology, a new high-performance public multi-chain project and a distributed trust collaboration platform, held a pre-launch of its MainNet on June 26th. It was announced that Ontology 1.0 will be officially released on June 30th. At the launch, Ontology’s Founder Jun Li gave a detailed introduction to the product structure, technical features, and governance models of the Ontology MainNet (Ontology 1.0) to one hundred blockchain industry elites from China and the USA. Ontology 1.0 provides new high-performance public blockchains that include a series of complete distributed ledgers and smart contract systems, and at the same time supports public chain customization and chain network collaboration, while continuously providing common modules in various distributed applications. Public chain basic services, a high-performance customisable blockchain framework, and protocol groups are the three key components of Ontology’s infrastructure. Ontology 1.0 includes a decentralised identity authentication protocol, distributed data management protocol, and credit score protocol. At the application level, the integrated client product (ONTO), trust search engine, and distributed data exchange framework will provide strong technical support.
Ontology partners attended to discuss blockchain technology solutions in real business scenarios. Partners who attended included: Contentos, who are committed to creating the world’s most extensive digital content public chain to reshape the content ecosystem; DAD (Decentralised Advertising), a blockchain digital advertisement platform; COT (Chains of Things), a smart hardware infrastructure solution platform; and CarBlock, the world’s first decentralised car market based on vehicle data.

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

MUSC Health and Alliance Oncology Expand Cancer Care in Beaufort, S.C.

Posted by fidest press agency su mercoledì, 7 febbraio 2018

san frnciscoSan Francisco. Alliance Oncology and the Medical University of South Carolina Health System (MUSC Health) announced today that they will partner with Beaufort Memorial Hospital to relocate and expand the hospital’s radiation oncology center to its main campus in late 2018. This project represents Alliance Oncology’s vision to be a driver in transforming healthcare by partnering with leading providers to expand regional services to communities – thus giving patients and their providers improved access, convenience and services closer to home. “In partnership with MUSC Health and Beaufort Memorial Hospital we are excited to add this location benefitting the local Beaufort community, and to augment academic cancer care services in the region,” said Greg Spurlock, President of Alliance Oncology. “As one of the nation’s leading providers of cancer care, this center will join Alliance affiliated locations across the country in providing high-quality, patient-centered services in partnership with premier cancer care providers and caregivers.” At the new Beaufort Memorial Keyserling Cancer Center, an MUSC clinical advisory committee will collaborate closely with local oncology experts and a dedicated clinical liaison will be onsite in the radiation oncology center. This expands upon the collaboration that was formed in 2016 when Beaufort Memorial Keyserling Cancer Center began enrolling qualifying cancer patients in clinical trials through an affiliation with the National Cancer Institute-designated Hollings Cancer Center at MUSC. “Given the needs of our patients throughout the state, it is imperative that we find innovative affiliations such as this one to ensure we are reaching all of those who need the expertise of our teams,” said Patrick J. Cawley, M.D., CEO, MUSC Health and Vice President for Health Affairs at Medical University of South Carolina. “We are excited and pleased to work with our colleagues at Alliance Oncology and Beaufort Memorial to bring the expertise of the Hollings Cancer Center even closer to those who need us.” “Beaufort Memorial Hospital has been providing outstanding cancer care to the community for more than a decade,” says Russell Baxley, MHA, President and CEO of Beaufort Memorial Hospital. “Our new and expanded partnership with MUSC and Alliance Oncology allows us to offer cutting-edge technology and resources locally, providing the latest in cancer care to our patients.”Alliance Oncology partners directly with hospitals and physicians to develop fully integrated oncology programs. Providing a full range of inpatient and outpatient service line capabilities, Alliance Oncology’s comprehensive approach to cancer care affords its partners the speed-to-market, quality clinical outcomes, patient satisfaction and operational expertise that sets them apart from the competition. (foto: san francisco)

Posted in Estero/world news | Contrassegnato da tag: , , | Leave a Comment »

San Francisco: Dermatology Summit

Posted by fidest press agency su domenica, 7 gennaio 2018

rob-danielsSan Francisco January 7, 2018 at 5:19pm Grand Ballroom, Palace Hotel, and the Biotech Showcase, January 8, 2018 at 10:45am Hilton San Francisco Union Square Dermatology Summit. Elastagen, a clinical-stage medical technology company with an advanced tissue repair platform based on tropoelastin, today announced that it will showcase the latest clinical developments and progress in its pioneering treatments at dermatology summit. Now in development, Elastagen’s tropoelastin tissue repair platform will include breakthrough treatments for acne scars, stretch marks, aesthetic skin repair and wound repair.
In a presentation titled, “Bringing tissue repair and regeneration to medical aesthetics and plastic surgery,” Elastagen Director and CEO Robert Daniels will offer new study data on tropoelastin. Among the findings of a new feasibility study of injectable tropoelastin for stretch marks were high safety outcomes and an 80% reduction in stretch mark depression volume, resulting in skin’s smoother look and feel. A full study will be submitted for publication in Q1 2018.
john-st-clair-robertshilton san franciscoElastagen executives are available for on-site meetings to update investors and media of the progress that Elastagen has made since it completed a $13M Series B equity financing. Additionally, the Company will share new data on the technology’s mechanism of action and how it improves skin’s structure and texture, as well as recent patient feedback. The Company is in the process of closing a Series C funding round, which includes current shareholders as well as new participants, and will raise $30M.
“We are pleased to begin 2018 at the Dermatology Summit at Biotech Showcase, sharing exciting new data on our tropoelastin platform,” Robert Daniels said. “Elastagen is gearing up for a pivotal year, when we expect to submit stretch mark, acne scar and aesthetic products for EU approval, in addition to making an IDE submission for a US clinical study for acne scars. We look forward to talking directly with physicians engaged in wound healing and aesthetics about the pioneering technologies developed by Elastagen.” (photo: rob daniels, john-st-clair-roberts)

Posted in Estero/world news, Medicina/Medicine/Health/Science | Contrassegnato da tag: , , | Leave a Comment »

Aids, sì Fda a pillola preventiva. In Italia si apre il dibattito

Posted by fidest press agency su martedì, 15 Maggio 2012

Fa discutere il sì espresso da un panel di esperti statunitensi in rappresentanza dell’Fda sull’utilizzo della prima pillola in grado di prevenire l’infezione da Hiv in soggetti sani. Il farmaco, in realtà due principi attivi tenofovir ed emtricitabina combinati assieme in un’unica compressa, è già in uso come trattamento per l’Hiv, ma non per la prevenzione e secondo le nuove indicazioni statunitensi sarebbe destinata a soggetti sani ad alto rischio, come omosessuali o partner di persone sieropositive. Secondo lo studio internazionale condotto in sei paesi e i cui risultati sono stati pubblicati nel 2010 sulla rivista The New England Journal of Medicine, l’utilizzo del farmaco a fini preventivi ha, infatti, dimostrato un minore rischio del 44-73% di contrarre l’infezione. «Penso» ha detto alla Bbc Robert Grant, del Gladstone Institutes of Virology and Immunology di San Francisco «che siamo nell’era che vedrà la fine dell’epidemia mondiale di Aids». Più cauti gli esperti italiani e se Stefano Vella, direttore del Dipartimento del farmaco dell’Istituto Superiore di Sanità (Iss), parla «di un’arma di prevenzione in più per le categorie altamente a rischio che non può essereconsiderata una soluzione», Mauro Moroni, vicepresidente di Anlaids sottolinea come «il profilattico possa svolgere la stessa azione preventiva sulle categorie a rischio, senza possibili effetti collaterali e senza costi enormi per l’Ssn e per i pazienti». Oggi negli Usa il trattamento con il farmaco costa da 11mila a 14 mila dollari l’anno, un costo da considerare, se il farmaco anche in Europa avesse un’indicazione di questo tipo, con il rischio che fondi siano distolti da opzioni terapeutiche che presentano una maggiore convenienza in termini di rapporto costi-benefici. Altri timori riguardano la possibilità che si sviluppino varianti del virus Hiv resistenti al farmaco «L’uso preventivo a vita di questo farmaco» secondo l’immunologo Ferdinando Aiuti «potrebbe portare a problemi di tossicità cumulativa, a un’inevitabile insorgenza di resistenze e quindi successiva inefficacia del farmaco stesso nei confronti del virus Hiv».(Marco Malagutti – fonte doctornews33)

Posted in Medicina/Medicine/Health/Science, Welfare/ Environment | Contrassegnato da tag: , , , | Leave a Comment »

Micron to Present NAND Outlook at 2012 Bank of America Merrill Lynch Technology Conference

Posted by fidest press agency su mercoledì, 9 Maggio 2012

San Francisco, Wednesday, May 9, 2:45 p.m. PT/5:45 p.m. ET (GLOBE NEWSWIRE) The Ritz-Carlton Hotel Micron Technology, Inc. (Nasdaq:MU), one of the world’s leading providers of advanced semiconductor solutions, today announced that Glen Hawk, vice president of their NAND Solutions Group, will address financial analysts attending the Bank of America Merrill Lynch 2012 Global Technology Conference on Wednesday, May 9 at 2:45 p.m. PT/5:45 p.m. ET. Mr. Hawk will address the global NAND market outlook, trends driving new storage consumption, and Micron’s silicon-to-systems strategy.
Audio from the session will webcast live from Micron’s Investor Relations website at The webcast will also be archived on the site and available for replay.

Posted in Estero/world news | Contrassegnato da tag: , , , | 1 Comment »

Conferenza Health care di J.P. Morgan

Posted by fidest press agency su mercoledì, 11 gennaio 2012

English: Main Street within the Texas Medical ...

Image via Wikipedia

Bologna.Silicon Biosystems SpA provider di tecnologie specializzate per la biologia molecolare e cellulare, ha annunciato che la società presenterà le proprie attività alla “30th Annual J.P. Morgan Healthcare Conference”, l’evento finanziario relativo al settore Health Care più importante al mondo. Domani alle ore 08.00 a San Francisco (CA), il senior management presenterà una panoramica delle attività della società e dei propri prodotti utilizzati nella ricerca di cellule tumorali circolanti, cellule fetali circolanti e di cellule staminali. Silicon Biosystems è un produttore di apparecchiature e kit medicali d’avanguardia per l’individuazione e l’isolamento di singole cellule, per la ricerca sul cancro e per quella sulla diagnosi prenatale non invasiva. La tecnologia DEPArray™, sviluppata e commercializzata dalla società, utilizza la microelettronica e i principi della dielettroforesi per individuare, separare e recuperare cellule rare, come le cellule tumorali circolanti (CTCs) che, una volta recuperate, possono essere sottoposte ad accurate analisi molecolari. La raccolta di popolazioni pure di cellule di interesse clinico da campioni biologici, come le CTCs, permette di acquisire molte importanti informazioni sulla rilevanza clinica di queste cellule, ben al di là del solo dato di conta fornito dalle apparecchiature attualmente esistenti, consentendo pertanto valutazioni in grado di indirizzare le terapie personalizzate.

Esistono molteplici opportunità di mercato, di dimensioni rilevanti e costituite da segmenti in significativa crescita, per le tecnologie capaci di isolare cellule rare e sottoporle a successive analisi molecolari. I prodotti di Silicon Biosystems sono attualmente usati per applicazioni di ricerca nei tumori metastatici, nelle malattie cardiovascolari, nella diagnosi prenatale e nell’area delle cellule staminali.
Il sistema DEPArray™ è utilizzato da centri ricerca di rilevanza internazionale presenti sia in Europa che negli USA. Alcuni dei centri che usano questo sistema per ricerche in oncologia sono: l’italiano IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), lo statunitense Fox Chase Cancer Center di Philadelphia, l’Università di Ratisbona in Germania ed il belga GZA (Gasthuis Zusters Antwerpen) di Anversa. In campo prenatale e/o cellule staminali alcuni dei centri che si sono dotati del DEPArray™ sono: il Baylor College of Medicine di Houston (USA), l’Istituto Mendel di Roma ed il CIBIO dell’Università di Trento.
Silicon Biosystems, Inc. nasce nell’Ottobre 2010 come società controllata di Silicon Biosystems, S.p.A. con sede a Bologna.

Posted in Medicina/Medicine/Health/Science, Università/University | Contrassegnato da tag: , , , | Leave a Comment »

Nicola Luisotti dirige i Berliner Philarmoniker

Posted by fidest press agency su sabato, 17 dicembre 2011

English: Description on flickr: Marcello Giord...

Image via Wikipedia

Berlino. Nicola Luisotti, direttore musicale dell’Opera di San Francisco, torna a dirigere i Berliner Philarmoniker. Tre date per un programma dedicato al XX secolo: dal 21 al 23 dicembre il direttore toscano sale sul podio di una delle più importanti orchestre sinfoniche del mondo per l’appuntamento che segna l’avvio di una stagione internazionale di concerti fra l’Europa (Italia compresa) e Stati Uniti. A Berlino, Luisotti – reduce da un’ intensa stagione a San Francisco – dirigerà i Berliner e il coro della Radio di Berlino assieme a due grandi solisti: il flautista Emmanuel Pahud e il soprano americano Leah Crocetto. Per il suo ritorno in Germania, il direttore italiano proporrà un programma raffinato: Debussy, Prokofiev, Poulenc e Berio. Emanuel Pahud eseguirà due rarità di Debussy e Berio per flauto solo. Leah Crocetto, acclamatissima Liù nella recente Turandot di San Francisco, sarà il soprano solista nel Gloria di Poulenc assieme al Rundfunk Chor di Berlino. Concluderà il concerto la sfolgorante sinfonia n° 5 di Prokofiev. Queste date segnano l’avvio di una stagione sinfonica intensa per Luisotti che all’inizio di febbraio sarà a Philadelphia, con musiche di Bach, Shostakovich e Rimskij Korsakov, e alla fine di febbraio a Madrid, per dirigere l’Orchestra Nacional d’Espagna in un programma dedicato a Mahler. Subito dopo, i primi di marzo, a Miami con la Cleveland Orchestra, per un concerto con musiche di Verdi, Golijov e Prokofiev. Infine, ritorno a fine marzo in Italia, per un doppio appuntamento al San Carlo di Napoli: la Messa di Puccini e la settima di Beethoven e l’opera I Masnadieri di Verdi, per la regia di Gabriele Lavia, che ha recentemente firmato la nuova produzione del Don Giovanni che Luisotti ha diretto nell’ ottobre scorso a San Francisco


Posted in Estero/world news, Mostre - Spettacoli/Exhibitions – Theatre | Contrassegnato da tag: , , , | Leave a Comment »

Lavoro: la legge controesodo a San Francisco

Posted by fidest press agency su lunedì, 10 gennaio 2011

11 gennaio a San Francisco, alle 18.00 ora locale, presso la sede del Consolato Italiano, 2590 Webster Street. La legge sugli incentivi fiscali per il rientro dei lavoratori, approvata lo scorso 23 dicembre, sarà presentata domani al Consolato italiano di San Francisco. Il progetto Controesodo approda negli Stati Uniti. La legge “Incentivi fiscali per il rientro dei lavoratori”, approvata lo scorso 23 dicembre, sarà infatti illustrata domani, martedì 11 gennaio, agli italiani residenti in California presso il nostro consolato a San Francisco. Saranno presenti – oltre al console Fabrizio Marcelli che terrà i saluti introduttivi – anche Guglielmo Vaccaro, deputato del PD e ideatore del progetto Controesodo, e il prof. Alberto Sangiovanni Vincentelli, docente a Berkeley.  Si tratta della prima uscita pubblica di Controesodo dopo l’approvazione della proposta elaborata all’interno dell’Associazione TrecentoSessanta di Enrico Letta e dell’Intergruppo parlamentare della Sussidiarietà. Primi firmatari Enrico Letta e Stefano Saglia; firmatari, tra gli altri, il vice presidente della Camera Maurizio Lupi, lo stesso Vaccaro, e relatori alla Camera e al Senato Alessia Mosca e Raffaele Fantetti.

Posted in Cronaca/News, Estero/world news | Contrassegnato da tag: , , , | Leave a Comment »